Human Vaccines

Global Market Trajectory & Analytics

MCP-1176

EXECUTIVE ENGAGEMENTS

POOL

5519
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

883
Interactions with Platform & by Email

PARTICIPANTS

166
Unique # Participated

VALIDATIONS

36
Responses Validated*

COMPANIES

16
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

108

PAGES

154

EDITION

16

PRICE

USD 5600

CODE

MCP-1176


COMPETITIVE METRICS

COMPANY

D S N T

% *

ADImmune Corporation

ALK-Abello A/S

AlphaVax, Inc.

Altimmune, Inc.

Astellas Pharma, Inc.

Bavarian Nordic A/S

Bharat Biotech International Ltd.

BioDiem Ltd.

BIOFABRI

Biokangtai

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Human Vaccines estimated at US$30.2 Billion in the year 2020, is projected to reach a revised size of US$43.2 Billion by 2027, growing at aCAGR of 5.2% over the period 2020-2027. Pediatric, one of the segments analyzed in the report, is projected to record 5% CAGR and reach US$24.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Adult segment is readjusted to a revised 5.5% CAGR for the next 7-year period.
The Human Vaccines market in the U.S. is estimated at US$8.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$8.9 Billion by the year 2027 trailing a CAGR of 8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 4.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

SELECT PLAYERS

ALK - Abelló A/S; Altimmune, Inc.; Astellas Pharma Inc.; Bavarian Nordic A/S; Bharat Biotech; BiondVax Pharmaceuticals Ltd.; GlaxoSmithKline Plc; Hualan Biological Engineering Inc.; Janssen Pharmaceuticals Inc.; MedImmune; Mitsubishi Tanabe Pharma; Pfizer Inc.; Sanofi Pasteur SA; Seqirus; Serum Institute of India Pvt. Ltd.; SK BioScience; Takeda Pharmaceutical Company Limited; Zydus Cadila

SEGMENTS

» Product Segment (Pediatric, Adult)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Human Vaccines: A Prelude
Recent Market Activity
Competitive Scenario
Vaccine Pricing: A Review
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
ALK - Abelló A/S (Denmark)
Altimmune, Inc. (USA)
Astellas Pharma Inc. (Tokyo)
Bavarian Nordic (Denmark)
BiondVax Pharmaceuticals Ltd. (Israel)
Bharat Biotech (India)
GlaxoSmithKline Plc. (UK)
Hualan Biological Engineering Inc. (China)
Janssen Pharmaceuticals, Inc. (USA)
MedImmune (USA)
Merck Sharp & Dohme Corp., (USA)
Mitsubishi Tanabe Pharma Corporate (Japan)
Pfizer, Inc. (USA)
Sanofi Pasteur SA (France)
Serum Institute of India Pvt. Ltd. (India)
Seqirus (UK)
SK BioScience (Korea)
Takeda Pharmaceutical Company Limited (Japan)
Zydus Cadila (India)
3. MARKET TRENDS & DRIVERS
Combination Vaccines Market Driven by Fast Expanding Pediatric Population
List of Combination Vaccines in the US: 2018
Gardasil 9 Offers Protection against HPV for Expanded Age Group
Increasing Demand for Recombinant Vaccines
Global Cholera Vaccines Market
Further Clinical Trials Needed for an Effective Zika Vaccine
Merck’s rVSV-ZEBOV Ebola Vaccine used for Ring Vaccination in Congo
Rising Dengue Cases Drive Vaccines Demand
Sanofi’s Dengue Vaccine First-to-Market
EMA Recommends Approval of Dengue Vaccine
Vaccine for AIDS
Staggering Global Statistics of AIDS - Opportunity Indicator
Toxoid Vaccines Market
H1N1 Vaccines Market
HSV Vaccine on the Horizon
Rising Disease Incidence and Increasing Awareness Drive the Global Meningococcal Vaccines Market
BCG Vaccines
Key TB Vaccine Candidates in the Pipeline: 2018
New Vaccine for Herpes Zoster or Shingles
Two-dose Hepatitis B Vaccine for Adults
Global Rotavirus Vaccines Market
Typhoid Vaccines Market
Measles Vaccines Market
DNA Vaccines: Engineering Growth
Mobile Money Encourages Parents for Vaccinating Children
Noninjectable Vaccines: Gain without Pain
Application of Botulinum Toxin as Delivery Mechanism for Oral Vaccines
Novel Technologies Ensure Timely Vaccine Delivery for Patients in Remote Locations
Smart mRNA Vaccines
Growing Pricing Pressure - A Major Market Deterrent
Safety Issues Come to the Fore
Novel Vaccination Guidelines Mitigate Risks Associated with Developing Shoulder Injuries
BioWarfare: Threat Perception and Preparedness
Overview of Potential Bio-Terrorist Agents
Smallpox (Variola Major)
Anthrax (Bacillus Anthracis)
Plague (Yersinia Pestis)
Botulism (Clostridium Botulinum)
Tularemia (Francisella Tularensis)
Tackling Cold Chain Issues
Trade Statistics
Growing Incidence of Infectious Diseases Drives the Global Human Vaccines Market
Total Number of Infectious Disease Covered under Vaccination
Conjugate Vaccines Rule in Human Vaccines Market
Pneumococcal Vaccines – A Major Segment
Vaccine Pipeline by Major Companies
GSK Vaccine Pipeline
Merck Vaccines Pipeline
Pfizer Vaccines Pipeline
Sanofi Vaccines Portfolio
Emergent BioSolutions Inc. - Vaccine Pipeline
Astellas Pharma - Vaccines
Pediatric Vaccines Dominate the Human Vaccines Market
Select Pediatric Vaccines
Adults Vaccine Market to Witness Rapid Growth, Driven by Government Initiatives
Select Adult Vaccines
Developed Markets Dominate, Emerging Regions to Exhibit the Fastest Growth
Pneumococcal Vaccines Market Set to Witness Rapid Growth
Influenza Vaccines Market: A High Growth Segment
Cancer Vaccines Market Offers Potential Opportunities
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Human Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Human Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Human Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pediatric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Adult by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Human Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Human Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Human Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
SPAIN
Spain Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
RUSSIA
Russia Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Human Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Human Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Human Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
INDIA
India Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Human Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Human Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Human Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
BRAZIL
Brazil Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
MEXICO
Mexico Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for Human Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Human Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Human Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
IRAN
Iran Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
ISRAEL
Israel Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
AFRICA
Africa Current & Future Analysis for Human Vaccines by Product Segment - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Human Vaccines by Product Segment - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Human Vaccines by Product Segment - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2012, 2020 & 2027
Total Companies Profiled: 16

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com